Literature DB >> 23392880

Taurine deficiency and MELAS are closely related syndromes.

Stephen W Schaffer1, Chian Ju Jong, Danielle Warner, Takashi Ito, Junichi Azuma.   

Abstract

MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a mitochondrial disease caused by one or more mutations of tRNA(Leu(UUR)). These mutations reduce both the aminoacylation of tRNA(Leu(UUR)) and a posttranslational modification in the wobble position of tRNA(Leu(UUR)). Both changes result in reduced transcription of mitochondria-encoded proteins; however, reduced aminoacylation affects the decoding of both UUG and UUA while the wobble defect specifically diminishes UUG decoding. Because 12 out of the 13 mitochondria-encoded proteins are more dependent on UUA decoding than UUG decoding, the aminoacylation defect should have a more profound effect on protein synthesis than the wobble defect, which more specifically alters the expression of one mitochondria-encoded protein, ND6. Taurine serves as a substrate in the formation of 5-taurinomethyluridine-tRNA(Leu(UUR)); therefore, taurine deficiency should mimic 5-taurinomethyluridine-tRNA(Leu(UUR)) deficiency. Hence, the wobble hypothesis predicts that the symptoms of MELAS mimic those of taurine deficiency, provided that the dominant defect in MELAS is wobble modification deficiency. On the other hand, if the aminoacylation defect dominates, significant differences should exist between taurine deficiency and MELAS. The present review tests this hypothesis by comparing the symptoms of MELAS and taurine deficiency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392880     DOI: 10.1007/978-1-4614-6093-0_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  The expanding world of tRNA modifications and their disease relevance.

Authors:  Tsutomu Suzuki
Journal:  Nat Rev Mol Cell Biol       Date:  2021-03-03       Impact factor: 94.444

2.  Tissue taurine depletion alters metabolic response to exercise and reduces running capacity in mice.

Authors:  Takashi Ito; Natsumi Yoshikawa; Stephen W Schaffer; Junichi Azuma
Journal:  J Amino Acids       Date:  2014-11-12

Review 3.  Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS.

Authors:  Syuichi Tetsuka; Tomoko Ogawa; Ritsuo Hashimoto; Hiroyuki Kato
Journal:  Metab Brain Dis       Date:  2021-06-12       Impact factor: 3.584

Review 4.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.